Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1970.7574.65 (+3.94 %)

PREV CLOSE ( ) 1896.10

OPEN PRICE ( ) 1880.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 38232

TODAY'S LOW / HIGH ( )1880.05 2005.00

52 WK LOW / HIGH ( )1200 2220.95

NSE1970.9075.1 (+3.96 %)

PREV CLOSE( ) 1895.80

OPEN PRICE ( ) 1894.00

BID PRICE (QTY) 1970.90 (16)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1474182

TODAY'S LOW / HIGH( ) 1891.00 2006.40

52 WK LOW / HIGH ( )1277.8 2220.95

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978

Management Info

Srinivas Sadu - Chairman - Managing Director

Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com / investor@glandpharma.com

Website www.glandpharma.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

14Jul Gland Pharma gets GMP Compliance Certi
Gland Pharma has received certificate of Good Manufacturing Practices (G..

14Jul Gland Pharma gains on getting GMP Comp
Gland Pharma is currently trading at Rs 1870.00, up by 10.95 points or 0..

03Jul Grant Of Stock Options Under Gland Ph
Grant of Stock Options under Gland Pharma Employee Stock Option Scheme S..

24Jun Gland Pharma gets EIR from USFDA for V
Gland Pharma has received Establishment Inspection Report (EIR) from Uni..

24Jun Gland Pharma soars on getting EIR from
Gland Pharma is currently trading at Rs. 1780.00, up by 36.20 points or..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	2899.99	10897.53
Gross Profit	3913.23	14655.85
Operating Profit	4378.41	16576.93
Net Sales	10303.53	41161.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1299.15 (13.58%)	M.Cap ( in Cr)392.77
RPG Life Sciences (BSE) 2645.50 (3.46%)	M.Cap ( in Cr)4375.40
Ajanta Pharma (BSE) 2786.30 (3.18%)	M.Cap ( in Cr)34804.26
NGL Fine-Chem (BSE) 1442.05 (5.00%)	M.Cap ( in Cr)890.90
Alkem Laboratories (BSE) 5000.10 (1.35%)	M.Cap ( in Cr)59783.70

Shareholding Pattern

	PROMOTERS	51.83%
	MUTUAL FUNDS/UTI	31.16%
	NON-INSTITUTION	7.99%
	FI/BANKS/INSURANCE	1.32%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	5.52
ICICI Pru MNC Fund(G)	3.67
ICICI Pru Pharma He...	3.57
Nippon India Pharma...	3.27
HDFC Pharma and Hea...	3.10
UTI Healthcare Fund...	3.00
UTI MNC Fund-Reg(IDCW)	2.72

Risk Disclosures on Derivatives

Smart Quotes

GLAND PHARMA LTD.